Skip to content
★ Sign in to follow
TR

Thomas Richard Fuerst

Executive
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€16k
▼ Sales (0 ops.)
—

Latest filing published 23 Nov 2011 for Altimmune, Inc., €4,709.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Thomas Richard Fuerst: trading record in brief

Thomas Richard Fuerst appears in our data through filings on Altimmune, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 10 November 2011 to 22 November 2011, the count stands at 2 filings.

No open-market sale appears; the market trades are 2 purchases worth €16k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 23 November 2011, the filings show an open-market purchase worth €4,709 in Altimmune, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas Richard Fuerst

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    SVP, Chief Scientific OfficerExecutivesAltimmune, Inc.
    6,350 USD0SEC
    5,000 shares@ US$1.27Common Stock, $0.0001 par value per shareSEC:0001144204-11-066716:0
    Canonical exit: 20 Feb 2012 (T+90)

1 of 1 declaration